Notes / Company

Haleos Labs Ltd.

HALEOSLABS BSE 540679 ISIN INE320X01016 Pharmaceuticals

Fundamentals

Market cap: ₹478 cr
P/E: 24.08×
ROE: 10.23%
Debt / equity: 0.43
Div yield: 0.09%
52-week range: 1067.00 — 1774.00

The timeline — 1 note on Haleos Labs Ltd.

May 2026

30 May 26 · 2:25 PM IST Brief

Brief · Earnings · Micro cap

Haleos Labs' FY26 profit drops 17% on 10% revenue slide

The annual results show a moderate, consistent earnings decline. A ₹1.50 dividend is maintained.

Verify on exchange BSE filings for HALEOSLABS NSE filings for HALEOSLABS